Free Trial

BioLife Solutions (BLFS) Competitors

BioLife Solutions logo
$25.65 0.00 (0.00%)
Closing price 08/26/2025 04:00 PM Eastern
Extended Trading
$25.10 -0.55 (-2.14%)
As of 07:16 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BLFS vs. TMDX, SLNO, NVST, LIVN, WRBY, INSP, PRCT, LQDA, LMAT, and AORT

Should you be buying BioLife Solutions stock or one of its competitors? The main competitors of BioLife Solutions include TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), LivaNova (LIVN), Warby Parker (WRBY), Inspire Medical Systems (INSP), PROCEPT BioRobotics (PRCT), Liquidia Technologies (LQDA), LeMaitre Vascular (LMAT), and Artivion (AORT). These companies are all part of the "medical equipment" industry.

BioLife Solutions vs. Its Competitors

BioLife Solutions (NASDAQ:BLFS) and TransMedics Group (NASDAQ:TMDX) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, earnings, profitability, institutional ownership, media sentiment, valuation and risk.

TransMedics Group has a net margin of 13.49% compared to BioLife Solutions' net margin of -5.39%. TransMedics Group's return on equity of 28.02% beat BioLife Solutions' return on equity.

Company Net Margins Return on Equity Return on Assets
BioLife Solutions-5.39% 0.16% 0.14%
TransMedics Group 13.49%28.02%8.64%

BioLife Solutions has a beta of 1.76, suggesting that its share price is 76% more volatile than the S&P 500. Comparatively, TransMedics Group has a beta of 2.09, suggesting that its share price is 109% more volatile than the S&P 500.

In the previous week, TransMedics Group had 5 more articles in the media than BioLife Solutions. MarketBeat recorded 14 mentions for TransMedics Group and 9 mentions for BioLife Solutions. BioLife Solutions' average media sentiment score of 1.41 beat TransMedics Group's score of 1.34 indicating that BioLife Solutions is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BioLife Solutions
7 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
TransMedics Group
9 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

TransMedics Group has higher revenue and earnings than BioLife Solutions. BioLife Solutions is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioLife Solutions$93.47M13.15-$20.18M-$0.12-213.75
TransMedics Group$441.54M8.89$35.46M$1.9359.68

BioLife Solutions presently has a consensus target price of $31.29, suggesting a potential upside of 21.97%. TransMedics Group has a consensus target price of $123.00, suggesting a potential upside of 6.79%. Given BioLife Solutions' stronger consensus rating and higher possible upside, research analysts clearly believe BioLife Solutions is more favorable than TransMedics Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BioLife Solutions
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
3.13
TransMedics Group
0 Sell rating(s)
3 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.78

93.2% of BioLife Solutions shares are held by institutional investors. Comparatively, 99.7% of TransMedics Group shares are held by institutional investors. 2.2% of BioLife Solutions shares are held by insiders. Comparatively, 7.0% of TransMedics Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

TransMedics Group beats BioLife Solutions on 11 of the 16 factors compared between the two stocks.

Get BioLife Solutions News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BLFS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BLFS vs. The Competition

MetricBioLife SolutionsMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$1.23B$10.68B$5.72B$9.73B
Dividend YieldN/A1.86%3.95%4.07%
P/E Ratio-213.7321.6130.3026.09
Price / Sales13.1531.39380.6987.72
Price / Cash209.3724.9137.7259.08
Price / Book3.543.529.936.67
Net Income-$20.18M$210.11M$3.27B$265.43M
7 Day Performance2.76%7.09%3.66%3.36%
1 Month Performance13.60%12.73%3.83%0.39%
1 Year Performance-0.77%-6.07%34.11%19.43%

BioLife Solutions Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BLFS
BioLife Solutions
2.614 of 5 stars
$25.65
flat
$31.29
+22.0%
-1.3%$1.23B$93.47M-213.73440News Coverage
Positive News
TMDX
TransMedics Group
2.7338 of 5 stars
$125.65
-1.5%
$123.00
-2.1%
-32.3%$4.35B$441.54M65.10210Positive News
Analyst Forecast
SLNO
Soleno Therapeutics
4.5613 of 5 stars
$68.09
-4.9%
$114.30
+67.9%
+50.9%$3.81BN/A-16.4530
NVST
Envista
3.6854 of 5 stars
$20.75
+0.5%
$20.92
+0.9%
+14.8%$3.43B$2.51B64.8312,300
LIVN
LivaNova
1.6218 of 5 stars
$53.27
-0.8%
$59.29
+11.3%
+21.4%$2.93B$1.25B-13.692,900Positive News
WRBY
Warby Parker
2.1782 of 5 stars
$27.38
+0.9%
$24.06
-12.1%
+70.5%$2.85B$771.32M-391.093,780Positive News
INSP
Inspire Medical Systems
4.9352 of 5 stars
$88.28
+0.6%
$165.62
+87.6%
-51.4%$2.60B$802.80M51.031,246Positive News
PRCT
PROCEPT BioRobotics
3.7098 of 5 stars
$40.71
-2.1%
$74.88
+83.9%
-48.1%$2.31B$224.50M-26.26430News Coverage
Positive News
LQDA
Liquidia Technologies
3.7258 of 5 stars
$27.72
+6.8%
$31.40
+13.3%
+182.1%$2.23B$14M-16.3150
LMAT
LeMaitre Vascular
1.9231 of 5 stars
$95.04
-0.9%
$98.00
+3.1%
+5.0%$2.17B$219.86M46.14490News Coverage
Positive News
AORT
Artivion
3.2269 of 5 stars
$42.81
0.0%
$39.80
-7.0%
+65.6%$2.02B$388.54M-101.921,600News Coverage
Analyst Upgrade
Insider Trade

Related Companies and Tools


This page (NASDAQ:BLFS) was last updated on 8/27/2025 by MarketBeat.com Staff
From Our Partners